Flavio Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared a post on X:
“Congrats to the ACCELERATE investigators for the first dedicated GBCA RCT to compare adjuvant chemotherapy vs chemoRT.
No diff in RFS between 6c GemOx or GemCis vs 3c chemo followed by 45 Gy of radiation with Cape (but closed early)
Consider enrolling patients in ECOG-ACRIN Cancer Research Group EA2197 in the US.”
More posts featuring Flavio Rocha.
